Epigenetic Biomarkers Hold Promise for Early Cancer Detection in Gastric and Colorectal Cancer

Strategic Insights -

Research presented from Mie, Japan, has highlighted the potential of epigenetic biomarkers, particularly DNA methylation and non-coding RNAs, in the early detection of gastric and colorectal cancer. According to a study published in Biochemical and Biophysical Research Communications, epigenetic alterations play a crucial role in cancer initiation and progression, and can be used as substrates for cancer detection. The study notes that aberrant epigenetic modifications occur at the earliest stages of neoplastic transformation and are essential players in cancer initiation and progression.

Key Takeaways:

  • Epigenetic biomarkers, including DNA methylation and non-coding RNAs, hold promise for early detection of gastric and colorectal cancer.
  • Disruption of epigenetic processes can lead to altered gene function and malignant cellular transformation.
  • Aberrant epigenetic modifications occur at the earliest stages of neoplastic transformation and are essential players in cancer initiation and progression.
  • Recent advances in epigenetics have allowed for the identification of clinically relevant putative biomarkers for cancer diagnosis.
  • Cell-free nucleic acids in systemic circulation have been identified as potential substrates for cancer detection.
  • DNA methylation and microRNA biomarkers have been shown to have the highest potential for cancer diagnosis.
  • The study discusses the obstacles that have limited the routine use of epigenetic biomarkers in clinical settings, including lack of standardization and validation.
  • Researchers Y. Toiyarna, Y. Okugawa, and A. Goel discussed approaches to overcome these hurdles and develop epigenetic biomarkers for clinical management of cancer patients.

Statistics:

  • 455(1-2) is the volume and issue number of the Biochemical and Biophysical Research Communications journal where the study was published.
  • 2014 is the year when a study on DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer was published.
  • 43-57 are the page numbers where the study was published in Biochemical and Biophysical Research Communications.
  • The study focused on the two most frequent cancers within the gastrointestinal tract, gastric and colorectal cancer.

Sources:

  • DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer. Biochemical and Biophysical Research Communications, 2014;455(1-2):43-57.
  • Biochemical and Biophysical Research Communications can be contacted at: Academic Press Inc Elsevier Science, 525 B St, Ste 1900, San Diego, CA 92101-4495, USA.
  • Additional information can be obtained by contacting Y. Toiyarna, Mie Univ, Inst Life Sci, Dept. of Gastrointestinal & Pediat Surg, Div Reparat Med, Tsu, Mie 5148507, Japan.